Medical Technology

Current search: ipo

@xconomy.com 6 days ago

Goldfinch Raises $100M for Kidney Drug Studies Now, Perhaps an IPO Later

@xconomy.com 2 months ago

Lyra Therapeutics IPO Raises $56M for Tests of Tech for Runny Noses

@xconomy.com 2 months ago

Bio Roundup: Fast FDA Approvals, Biogen Delays, ORIC’s IPO & More

@xconomy.com 4 months ago

Bio Roundup: Gilead’s $4.9B Deal, COVID-19 Collabs, IPO Plans & More

@xconomy.com 4 months ago

Revolution Medicines IPO Reels In $238M to Take On RAS in Cancer

@xconomy.com 5 months ago

Revolution Medicines Maps Out an IPO to Reach Cancer’s Frontiers

@xconomy.com 5 months ago

Schrödinger Sets Course for IPO to Support Growing Internal Pipeline

@xconomy.com 6 months ago

Black Diamond Lines Up IPO as Lead Cancer Drug Nears Clinic

@xconomy.com 9 months ago

SpringWorks and Satsuma Boost This Week’s Biotech IPO Haul to $595M

@xconomy.com 10 months ago

Frequency Plans IPO for Hearing Loss Drug & More Regenerative Meds

@xconomy.com 10 months ago

Pfizer Spinout SpringWorks, Migraine Drug Firm Satsuma Prep IPOs

@xconomy.com 1 year ago

Bio Roundup: Head and Spine Previews, Biogen Moves, IPO Dreams & More

@xconomy.com 1 year ago

Acelity Sells to 3M in Deal Valued at $6.7 Billion, Ending IPO Plan

@xconomy.com 1 year ago

Bio Roundup: Moderna’s IPO, Arena’s Comeback, E-Cig Survey & More

@xconomy.com 1 year ago

Synthorx Files for IPO to Advance Enhanced Cytokine Drugs

@xconomy.com 1 year ago

Bio Roundup: BIO Diversity, Allogene IPO, CRISPR In Utero & More

@xconomy.com 1 year ago

Six Life Science Firms Close Q3 with an IPO, More Are on the Way

@techcrunch.com 1 year ago

Public shareholders got high today on Tilray, the first marijuana company to IPO on Nasdaq

@xconomy.com 2 years ago

IPO Wave Rolls On as Five Life Science Firms Haul in $651M